MedPath

Shrunken Pore Syndrome: a Retrospective, Single Center, Cohort Study

Completed
Conditions
Kidney Diseases
Registration Number
NCT04141072
Lead Sponsor
Henrik Bjursten
Brief Summary

To study the impact a difference in renal clearance of small and large molecules has on long-term survival.

Detailed Description

Renal dysfunction is considered a major risk factor in cardiac surgery. Renal function has earlier been estimated by creatinine and more recently by cystatin C, both of which are analysed in a blood sample. New evidence seems to suggest that if the ratio between estimated renal function from cystatin C and creatinine is below 60% the patient has a higher rate of mortality irrespective of renal function. This syndrome is named Shrunken Pore Syndrome.

We study patients whom have undergone elective cardiac surgery at our institution and on whom we before the surgery has collected blood samples. They are all included in our in house patient registry and qulaity database and afterwards we match this data to our national tax registry to get data on mortality.

Our aim is to evaluate whether Shrunken Pore Syndrome influence mortality following elective cardiac surgery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
4719
Inclusion Criteria
  • Elective CABG and/or sAVR at the department of Cardiothoracic Surgery, Skåne University Hospital in Lund, Sweden between 1 January 2010 and 31 December 2015.
Exclusion Criteria
  • Emergency operation
  • Redo operation
  • Preoperatively missing cystatin C or creatinine

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mortality during follow up1 January 2010 - 1 January 2019

All cause mortality at follow up

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Skåne University Hospital

🇸🇪

Lund, Skåne, Sweden

© Copyright 2025. All Rights Reserved by MedPath